Clinical Cancer Research, 2023
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer

Bessede A., Peyraud F., Besse B. et al.

Blood Advances, 2023
Clinical and immunological features in ACKR1/DARC-associated neutropenia

Palmblad J., Sohlberg E., Nilsson C. et al.

European Journal of Heart Failure, 2023
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials

Ferreira J., Butler J., Anker S. et al.

eBioMedicine, 2023
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial

Zhang X., Irajizad E., Hoffman K. et al.

Scientific Reports, 2023
Using trials of caloric restriction and bariatric surgery to explore the effects of body mass index on the circulating proteome

Goudswaard L., Smith M., Hughes D. et al.

Cancers, 2023
Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor

Stensgaard S., Thomsen A., Helstrup S. et al.

Nature Communications, 2023
Plasma proteomic profiles predict individual future health risk

You J., Guo Y., Zhang Y. et al.

Circulation: Genomic and Precision Medicine, 2023
Plasma Protein Profiling of Incident Cardiovascular Diseases: A Multisample Evaluation

Lind L., Titova O., Zeng R. et al.

ESC Heart Failure, 2023
Sex‐specific cardiovascular protein levels and their link with clinical outcome in heart failure

de Bakker M., Loncq de Jong M., Petersen T. et al.

Journal of Thrombosis and Haemostasis, 2023
Proteomic insights into modifiable risk of venous thromboembolism and cardiovascular comorbidities

Yuan S., Xu F., Zhang H. et al.

Scientific Reports, 2023
Changes in natural killer and T lymphocyte phenotypes in response to cardiovascular risk management

Good E., Åkerman L., Nyström S. et al.

Pediatric Research, 2023
Antisecretory factor in breastmilk is associated with reduced incidence of sepsis in preterm infants

Gustafsson A., Johansson E., Henckel E. et al.

iScience, 2023
Hospital-treated prevalent infections, the plasma proteome and incident dementia among UK older adults

Beydoun M., Beydoun H., Noren Hooten N. et al.

Frontiers in Immunology, 2023
Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay

Kmezic I., Gustafsson R., Fink K. et al.

Scientific Reports, 2023
Galectin-4 is associated with diabetes and obesity in a heart failure population

Dieden A., Gudmundsson P., Korduner J. et al.

Frontiers in Immunology, 2023
Olink proteomics analysis uncovers the landscape of inflammation-related proteins in patients with acute compartment syndrome

Wang T., Yang S., Long Y. et al.

Molecular Neurobiology, 2023
Causal Association of Cytokines and Growth Factors with Stroke and Its Subtypes: a Mendelian Randomization Study

Chen G., Lin T., Wu M. et al.

European Journal of Cancer, 2023
FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction

van Eijck C., Strijk G., Vietsch E. et al.

Scientific Reports, 2023
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study

Mynster Kronborg T., Webel H., O’Connell M. et al.

European Journal of Heart Failure, 2023
Growth differentiation factor‐15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program

Ferreira J., Packer M., Butler J. et al.